Biotech

All Articles

FDA extends probe into Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the provider's prospective MDMA-assisted therapy for post-traumatic ...

Gene editor Volume giving up 131 workers

.Just days after gene editor Volume Biosciences announced confidential working slices, a more clear ...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Therapeutics is actually giving up a fourth of its staff as the oncology biotech scales back...

J &amp J apply for FDA authorization of $6.5 B autoimmune medicine

.Johnson &amp Johnson has gotten yet another measure toward noticing a return on its own $6.5 billio...

Gain's phase 1 gain paves method to prove Parkinson's medicine's worth

.Gain Therapies has established its sights on showing the effectiveness of its own Parkinson's disea...

Actinogen reports brand new stage 2 records to save clinical depression medicine

.Actinogen Medical's chances-- as well as supply rate-- have rebounded somewhat from earlier this mo...

Pfizer and Main include Ratio to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have actually added Quotient into their 10-program partnership, ...

Bayer pens $547M pact to press perimeters of noncoding RNA

.Bayer executives were eager to anxiety to Brutal this summer season that the German pharma titan's ...

UK unveils plannings to launch 18 brand new clinical trial centers

.Amid a yearslong scientific trial decrease in the U.K., a new public-private relationship has arise...

UPDATE: Genentech telegraphs 93 discharges in The golden state after sharing plannings to shutter cancer cells immunology investigation system

.Following the announcement of a big discharge shot in April and a major restructuring project unvei...